MedPath

Is there an association between a postpartum venous thromboembolism risk assessment chart and the results of either two different means of determining clot formation, using a sample of blood?

Not Applicable
Recruiting
Conditions
Risk assessment of deep vein thrombosis in postpartum women
Reproductive Health and Childbirth - Fetal medicine and complications of pregnancy
Registration Number
ACTRN12619000050156
Lead Sponsor
Darren Lowen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
130
Inclusion Criteria

Postpartum of a live neonate, within 60 minutes of the delivery of the placenta, in an individual who has capacity to consent to the request for a sample of blood

Exclusion Criteria

Inability to provide consent for the request of a sample of blood and fetal death at the time of birth

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Venous thromboembolism risk assessment as assessed by clot strength determined by the use of ROTEM[The primary timepoint is within one hour post delivery of the placenta];Venous thromboembolism risk assessment, as measured by blood 'clotability', using the Thrombin Generation Assay[Within one hour post delivery of the placenta]
Secondary Outcome Measures
NameTimeMethod
There are no secondary outcomes[Not applicable]
© Copyright 2025. All Rights Reserved by MedPath